RxDoctor Payments Data

Salvatore Savona, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1841533312

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (56.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medtronic at 54.8% of the total.

$48,730in general payments, 2019–2025

Across 128 payments — averaging $380.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$27K
  • Boston Scientific$10K
  • Biosense Webster, Inc.$10K
  • Abbott$1K
  • Altathera Pharmaceuticals LLC$195
  • Medical Device Business Services, Inc.$94
  • plus $61 from 2 others
$200,372in research payments, 2019–2025

Across 65 payments — averaging $3082.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Adagio Medical, Inc.$86K
  • Biosense Webster, Inc.$73K
  • Medtronic$31K
  • Impulse Dynamics (USA) Inc.$10K

What the payments were for

  • Consulting fees$7,70016%
  • Grants$27,74557%
  • Travel & lodging$7,28615%
  • Food & beverage$6,00012%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,730 in reported general payments places this provider in the 80th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$193,100
Medicare patients
1,152
Services billed
1,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban181$199,551
XareltoRivaroxaban55$68,477
Dofetilide38$8,478
Mexiletine Hcl28$5,246
Amiodarone Hcl114$3,382
SotalolSotalol Hcl107$2,637
Metoprolol Succinate121$1,677
Flecainide Acetate21$1,661
Diltiazem 24hr Er (Cd)Diltiazem Hcl39$861
Metoprolol Tartrate23$155
Warfarin Sodium16$139
Carvedilol15$105
ClopidogrelClopidogrel Bisulfate11$33

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →